| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 958 | 3.943 | 1.720 | 0 | 14.602 |
| Total Income - EUR | - | - | - | - | - | 958 | 3.943 | 1.720 | 0 | 14.602 |
| Total Expenses - EUR | - | - | - | - | - | 1.627 | 4.785 | 4.019 | 0 | 12.322 |
| Gross Profit/Loss - EUR | - | - | - | - | - | -669 | -842 | -2.300 | 0 | 2.280 |
| Net Profit/Loss - EUR | - | - | - | - | - | -698 | -961 | -2.351 | 0 | 1.915 |
| Employees | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Gustare Bio S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 232 | 227 | 228 | 227 | 188 |
| Current Assets | - | - | - | - | - | 1.244 | 1.469 | 126 | 125 | 6.733 |
| Inventories | - | - | - | - | - | 349 | 1.142 | 0 | 0 | 3.092 |
| Receivables | - | - | - | - | - | 0 | 0 | 0 | 0 | 49 |
| Cash | - | - | - | - | - | 895 | 327 | 126 | 125 | 3.592 |
| Shareholders Funds | - | - | - | - | - | -657 | -1.603 | -3.959 | -3.947 | -2.010 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 2.133 | 3.299 | 4.312 | 4.299 | 8.931 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "5630 - 5630" | |||||||||
| CAEN Financial Year |
5630
|
|||||||||
Comments - Gustare Bio S.r.l.